Researchers from the Wellcome Sanger Institute and their collaborators used whole genome sequencing to study when BCR::ABL1—an abnormal fusion of the different genes called BCR and ABL1 ...

New Delhi: Novartis Healthcare has got approval from the Subject Expert Committee (SEC) functional under the Central Drug ...

Living with CML can be challenging. Fortunately, these advances in CML treatment offer hope beyond daily pills.

Unlike most cancers, which require multiple genetic ‘hits’ to drive malignancy, CML is driven by a single abnormal genetic event: the fusion of the BCR and ABL1 genes to form BCR::ABL1 ...